Primary Sclerosing Cholangitis (PSC)

Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.

Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.

PUBLIC PAGE
Jul 29, 2019

IBD: A Comorbidity of PSC

By Konstantinos N. Lazaridis, M.D. @klazaridis
  The majority of patients with the PSC have Inflammatory Bowel Disease (IBD). In this presentation, Dr. Laura Raffals, Associate Professor of Medicine, Mayo Clinic College of Medicine provides a comprehensive review of the epidemiology, diagnosis, outcomes and management of IBD among PSC patients. View the [...]
IBD: A Comorbidity of PSC
Jul 15, 2019

PSC and Inflammatory Bowel Disease (IBD): Women’s Health Issues

By Konstantinos N. Lazaridis, M.D. @klazaridis
Female patients with the PSC and inflammatory bowel disease (IBD) have unique health and disease issues to deal with. During the 15th Annual Conference of the “PSC Partners Seeking a Cure”", Dr. Alina Allen, Assistant Professor of Medicine, Mayo Clinic College of Medicine, and Dr. Laura Raffals, Associate [...]
PSC and Inflammatory Bowel Disease (IBD): Women’s Health Issues
Jul 1, 2019

Genes and Environment in PSC

By Konstantinos N. Lazaridis, M.D. @klazaridis
On May 21-23, 2019, the 15th Annual Conference of the “PSC Partners Seeking a Cure” took place in Rochester, Minnesota. More than 315 patients and family members attended the meeting. We are honored and grateful that “PSC Partners Seeking a Cure” choose Rochester and Mayo Clinic as their destination [...]
Genes and Environment in PSC
Jun 17, 2019

Alterations of the bile microbiome in Primary Sclerosing Cholangitis

By Ethan McConkey, Moderator @ethanmcconkey
In a study published this month in Gut, T. Liwinski, et al., reports on the differences of the microbiome and bile acid composition seen in the bile fluid of patients with PSC compared with healthy controls. 43 patients with PSC and 22 controls were included and bile specimens were [...]
Alterations of the bile microbiome in Primary Sclerosing Cholangitis
Jun 3, 2019

PSC literature elsewhere: Ursodeoxycholic acid therapy in pediatric PSC

By Konstantinos N. Lazaridis, M.D. @klazaridis
Recently, we have made the decision to include periodically in our PSC blog commentaries of selected clinical studies published by other groups. This tactic aims at keeping the followers of this blog informed about current efforts of the academic community at large to better understand and treat PSC. [...]
PSC literature elsewhere: Ursodeoxycholic acid therapy in pediatric PSC

Invite Others

Send an email to invite people you know to join the Primary Sclerosing Cholangitis (PSC) page.

We'll include this text in the user's invitation.